We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Xenogen Announces Second Agreement With Gene Logic

News   Oct 14, 2005

 
Xenogen Announces Second Agreement With Gene Logic
 
 
 

RELATED ARTICLES

How Anti-psychotic Medications Drive Weight Gain

News

About three million Americans take antipsychotic medications for conditions such as bipolar disorder, PTSD and schizophrenia. These medications are vital for mental health, yet many people stop taking them because of the side effects of weight gain and associated metabolic diseases.

READ MORE

Compound Blocks Common Genetic Cause of ALS & Frontotemporal Dementia

News

Writing in the journal Cell Chemical Biology, Scripps Research chemist Matthew Disney, PhD, and colleagues describe a new compound that blocks the most common genetic cause of both familial ALS and frontotemporal dementia.

READ MORE

New Strains of Hepatitis C Found in Africa

News

Three new strains of hepatitis C have been found circulating in the general population in sub-Saharan Africa, suggesting that certain antiviral drugs currently used in the West may not be as effective against the new strains.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE